Hostname: page-component-cd9895bd7-gbm5v Total loading time: 0 Render date: 2024-12-26T06:46:58.905Z Has data issue: false hasContentIssue false
  • English
  • Français

Special Report: Economic Incentives in Nosocomial Infection Control

Published online by Cambridge University Press:  02 January 2015

Bernard Friedman
Bernard Friedman*
Affiliation:
Center for Health Services and Policy Research, Northwestern University, Evanston, Illinois
*
Center for Health Services and Policy Research, Northwestern University, Evanston, IL 60201
Get access Rights & Permissions [Opens in a new window]

Extract

To a new student in this field, with a background in the economics of health care financing and insurance, there appear to be many challenging issues regarding: a) the efficacy of particular infection control measures; b) the calculation of economic benefit from particular measures; c) the determinants of the actual levels of expenditure on infection control and the measures actually adopted; and d) the rationale and pitfalls of regulatory standards such as those recommended by the Centers for Disease Control or adopted by the Joint Commission on Accreditation of Hospitals.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 4 , Issue 2 , April 1983 , pp. 103 - 106
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1983

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.McGowan, JE JrCost and benefit in control of nosocomial infection: Methods for analysis. Rev Infect Dis 1981;3:790–797.CrossRefGoogle ScholarPubMed
2.Spengler, RF, Greenough, WB III, Hospital costs and mortality attributed to nosocomial bacteremias. JAMA 1978;240:2455.CrossRefGoogle ScholarPubMed
3.McGowan, JE Jr, Parrott, PL, Duty, VP, Nosocomial bacteremia: Potential for prevention of procedure-related cases. JAMA 1977;237:2727.CrossRefGoogle ScholarPubMed
4.Christiansen, JB, The impact of HMOs: Evidence and research issues, J Health Polit Policy Law 1980;5:355.Google Scholar
5.Richardson, WC, Diehr, PK, Lo Gerfo, JP, et al: Comparisons of prepaid health care plans in a competitive market: The Seattle prepaid health rare project. US Dept Health and Human Services, publication No. (PHS) 80-3199, 1980.Google Scholar
6.Haley, RW, Shachtman, RH, The emergence of infection surveillance and control programs in US hospitals: An assessment, 1976. Am J Epidemiol 1980;111:574.CrossRefGoogle ScholarPubMed
7.Peltzman, S, The effects of automobile safety regulation. Journal of Political Economy 1975;83:677.CrossRefGoogle Scholar